KINETICS OF IMMOBILIZED HEPARINASE IN HUMAN BLOOD

被引:1
作者
FREED, LE
VUNJAKNOVAKOVIC, GV
BERNSTEIN, H
COONEY, CL
LANGER, R
机构
[1] MIT, DEPT CHEM ENGN, E25-342, 77 MASSACHUSETTS AVE, CAMBRIDGE, MA 02139 USA
[2] MIT, DIV HLTH SCI & TECHNOL, CAMBRIDGE, MA 02139 USA
[3] UNIV BELGRADE, DEPT CHEM ENGN, BELGRADE, YUGOSLAVIA
[4] ENZYTECH CO, CAMBRIDGE, MA USA
关键词
IMMOBILIZED ENZYME REACTOR; HEPARINASE KINETICS; BLOOD DEHEPARINIZATION; BIOREACTOR MODELING;
D O I
10.1007/BF02368166
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Immobilized enzyme reactors can form the basis of useful blood detoxification systems. One such reactor was developed for heparin neutralization by immobilized heparinase. In this article, reactor kinetics were studied under clinically relevant conditions. Heparin neutralization was assessed in vitro in whole human blood using (a) a well-mixed batch reactor, and (b) an oscillating, continuous-flow reactor. The kinetics of heparin neutralization in human blood were first order over the entire range of heparin and enzyme concentrations and particle fractions tested. The kinetic rate was not sensitive to physiological variations in the concentration of antithrombin, a heparin binding protein in blood. Enzyme activity did not decrease significantly over the 2 hour test period. Kinetic control of the system with minimal intraparticle diffusional limitations was suggested by the Thiele moduli (0.11-0.67) and effectiveness factors (0.98 +/- 0.01). The ratio k(cat)/K(m) obtained in batch studies was 0.0028 +/- 0.0008 cm3/mug-min. A continuous-flow oscillating reactor within a closed recirculation loop performed as a single well mixed batch reactor; there was a short mixing time of recirculating blood when compared to reaction time. A model based on this mixing pattern and the kinetics obtained in independent batch studies accurately predicted heparin neutralization profiles observed in the continuous-flow system.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 21 条
[1]   EVALUATION OF CRITICAL GROUPS REQUIRED FOR THE BINDING OF HEPARIN TO ANTITHROMBIN [J].
ATHA, DH ;
STEPHENS, AW ;
ROSENBERG, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (04) :1030-1034
[2]  
Bailey J., 1977, BIOCH ENG FUNDAMENTA
[3]   EXTRACORPOREAL ENZYMATIC HEPARIN REMOVAL - USE IN A SHEEP DIALYSIS MODEL [J].
BERNSTEIN, H ;
YANG, VC ;
LUND, D ;
RANDHAWA, M ;
HARMON, W ;
LANGER, R .
KIDNEY INTERNATIONAL, 1987, 32 (04) :452-463
[4]   EXVIVO MODEL OF AN IMMOBILIZED-ENZYME REACTOR [J].
BERNSTEIN, H ;
LANGER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) :8751-8755
[5]   IMMOBILIZED HEPARINASE - INVITRO REACTOR MODEL [J].
BERNSTEIN, H ;
YANG, VC ;
LANGER, R .
BIOTECHNOLOGY AND BIOENGINEERING, 1987, 30 (02) :239-250
[6]   BIOREACTOR BASED ON SUSPENDED PARTICLES OF IMMOBILIZED ENZYME [J].
FREED, LE ;
VUNJAKNOVAKOVIC, GV ;
DRINKER, PA ;
LANGER, R .
ANNALS OF BIOMEDICAL ENGINEERING, 1993, 21 (01) :57-65
[7]  
FREED LE, 1991, ASAIO, P96
[8]  
FREED LE, 1991, MACROSCOPIC MICROSCO, P55
[9]  
HORROW JC, 1985, ANESTH ANALG, V64, P348
[10]  
JORDAN RE, 1980, J BIOL CHEM, V255, P81